This report is a global intelligence database on diabetes drugs & devices, which offers data on 25 major countries.
It covers 13 years of comparable data, including 5-year forecasts incorporating value, volume sales, and price and price per-capita expenditure. The Intelligence Centre enhances your understanding of the diabetes drugs industry, along with economic factors impacting diabetes drug usage, such as diabetes population, Type 1 and Type 2 Diabetic population, and obesity, which provide you with actionable business insights.
Diabetes drugs & devices market data, volume and value analytics with growth trends (2012-2023)
Branded & generic drugs and devices' sales data from 2012-2023
Segment, sub-segment & company devices' sales data from 2012-2023
Additional information includes - diabetic population levels, diabetes prevalence, Diabetes Type 1 population, Diabetes Type 2 population, and per-capita expenditure.
Abbott Diabetes Care
Ascensia Diabetes Care
Bristol Myers Squibb
Johnson & Johnson
Merck and Co.
Diabetes Drug Categories:
Basal Insulin or Long-acting Insulin
Bolus Insulin or Fast-acting Insulin
Pre-mixed Insulin or Combination Insulin
Traditional Human Insulins
Traditional Human Insulin Biosimilars
Insulin Glargine Biosimilars
GLP-1 Agonist Market
Oral Anti-diabetics Drugs
Dopamine-D2 Receptor Agonist
Diabetes Device Categories
Cartridges in Reusable Pens
Insulin Pump Devices
Insulin Pump Reservoirs
Self-monitoring Blood Glucose Devices (SMBG)
Continuous Glucose Monitoring Devices (CGM)
CGM durables (Receivers and Transmitters)
The global diabetes care market is expected to grow because of the growing diabetes population levels and increasing diabetes expenditure in established, as well as pharm emerging countries.
Global Rise in Diabetic Population
There has been a tremendous increase in the global diabetic population levels over the past decade. Several reports and surveys documented a drastic increase in the diabetic population levels, based on the changing lifestyles and habits.
Extensive urbanization in various parts of the globe is considered to be the primary cause of obesity, health deterioration, physical inactivity, etc. Owing to these factors the prevalence of Type 2 Diabetes mellitus (T2DM) has increased significantly.
It is estimated that out of the total 415 million people suffering from diabetes worldwide, 46% of this demographic is those with undiagnosed diabetes.
The growing diabetic population levels act as a driver for insulin monitoring devices, such as glucometers, CGMs, etc. In developed countries, close to 90% of Type 1 Diabetic patients use glucometers. It is expected that during the forecast period close to 50% of Type 2 Diabetic patients will use a glucometer.
The United States Leads the Diabetes Drugs & Devices Market
In 2017, the US diabetes drugs market held the largest market share in North America, due to the presence of a high-quality healthcare system and increasing prevalence of diabetes in the region.
In the Asia-Pacific region, China and India have been identified as potential emerging markets, due to the rising diabetic population levels.
Reasons to Purchase this Dashboard
More Granular: Covers more categories, segments and brands' information at country- and global-levels compared to other market intelligence providers
Analyzing the outlook of the market with recent market data, historical data and market forecast
Ease of Comparability: Analytics are based on a standardized definition across the globe to facilitate better comparability of market data
View the market in different ways among categories and geography to understand where actual opportunities lie
Market segmentation including quantitative research, incorporating the impact of economic and non-economic aspects
Regional- and country-level data integrating the demand and supply forces which are influencing the growth of the market
Market value (in USD million) and volume data for each segment and sub-segment
Understanding of the market based on value and volume changes, intra category competition.
Dedicated analyst support for research queries and training
Continuous yearly amendment of the database with significant changes updated based on scenarios
Key Topics Covered:
2. Research Approach and Methodology
3. Market Segmentation
3.1 By Drug
3.2 By Device
4. Market Indicators
5. Company Share Analysis
For more information about this report visit https://www.researchandmarkets.com/r/dikqn7
View source version on businesswire.com: https://www.businesswire.com/news/home/20211206005626/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900